Recursion · 13 hours ago
Vice President, Translational Computational Biology
Salt Lake City, Utah
Full-time
Hybrid
Director/Executive
$319K/yr - $414K/yr
7+ years expRecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. As the Vice President of Translational Computational Biology, you will set the strategy and drive the implementation of connecting data from genome-scale -omics platforms with patient-derived genetics, leveraging advanced analytics to identify novel biological insights for drug development.
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Responsibilities
Identify and set the strategy on technological and analytical advances in the computational biology field that will directly advance Recursion's portfolio and its mission to industrialize drug development
Mentor teams to develop technologies to address specific questions that move multiple drug program and partnership projects forward
Collaborate with Recursion's research-oriented teams to evaluate new technologies and decide on which to transition toward scaled production
Lead the strategy and implementation efforts to identify optimal disease and patient linkages to our -omics phenotypes, along with the discovery and validation of translational biomarkers and patient selection solutions to drive precision medicine for our therapeutic programs
Be a key member to contribute to the strategy for the collection of patient genetic and biomarker data in Recursion clinical trials for reverse translation, while also being a key member to contribute to the strategy in support of the Recursion OS and clinical portfolio, building and nourishing strong links between computational biology and the larger cross-functional organization
Collaborate with groups in discovery biology, chemistry, and data science to rapidly deliver a portfolio of therapeutic programs to the clinic
Guide teams of computational biologists and data scientists in executing the above strategy to industrialize the process of turning maps into medicines
Qualification
Required
7+ years applying expertise in computational biology in service of advancing drug discovery and drug development programs. Particular consideration will be given to candidates with experience in oncology
Experience working in partnerships with both wet-lab and computational components
Demonstrated ability to manage multiple project teams with cross-functional delivery goals
A track-record for pairing large-scale patient/population datasets in a closed loop with high-throughput in vitro functional genomics to transform the process of identifying targets, models, and biomarkers with patient connectivity and validity
Experience in developing and implementing patient stratification / precision medicine solutions in clinical development leveraging multi-omics and clinical data and well versed in regulatory considerations
Strong leadership of a multi-level management tree fostering an inclusive and diverse group with a passion for developing world-class talent in a matrixed environment
Curiosity and the professional skill-set to excel in an open, highly collaborative, and growth-oriented environment
Benefits
Annual bonus
Equity compensation
Comprehensive benefits package
Company
Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives.
501-1000 employees
H1B Sponsorship
Recursion has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (6)
2024 (6)
2023 (5)
2022 (2)
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$865.38MKey Investors
NVIDIAKinnevikLeaps by Bayer
2024-06-26Post Ipo Equity· $200M
2023-07-12Post Ipo Equity· $50M
2022-10-25Post Ipo Equity· $150M
Leadership Team
Chris Gibson
Co-Founder and CEO
Ben Mabey
Chief Technology Officer
Recent News
MenloVentures
2025-12-31
Hartford Business Journal
2025-12-30
felicis.com
2025-12-29
Company data provided by crunchbase